Joshua P. Smalley

Joshua P. Smalley

Auto-generated profile, based on publicly available information

Joshua P. Smalley

Institute for Structural and Chemical Biology

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2025 in Journal of the American Chemical Society
Verified
Journal Article
Open access
WPWiktoria A. Pytel
Wiktoria A. Pytel
UPUrvashi Patel
Urvashi Patel
JSJoshua P. Smalley
Joshua P. Smalley
CMChristopher J. Millard
Christopher J. Millard
EBEdward A. Brown
Edward A. Brown
JSJohn W. R. Schwabe
John W. R. Schwabe
Class I histone deacetylases regulate gene transcription and are established therapeutic targets. HDAC1-3 form the catalytic subunit in several distinct multiprotein complexes; however, HDAC inhibitors are rarely studied in the context of these complexes. We evaluated multiple inhibitors, using seven HDAC complexes, and found that the inhibition profiles were highly complex-dependent, despite targeting the same enzyme. We also investigated the effect of the allosteric regulator inositol phosphate on these inhibitors. We observed very large, complex-selective reductions in the potency of benzamides bearing a "foot-pocket group", proposed to be selective for HDAC1/2. The potencies of these compounds are likely to be profoundly different in vivo compared with in vitro potencies in the absence of inositol phosphates. Our findings are supported by cell-based assays evaluating histone acetylation and HDAC degradation, highlighting the importance of evaluating HDACi in the context of HDAC complexes and inositol phosphates.